Labcorp: Covance not adding capacity despite preclinical recovery
Covance will not add more capacity in the near future despite increased demand and improving preclinical sector pricing, Labcorp’s management says.
Covance will not add more capacity in the near future despite increased demand and improving preclinical sector pricing, Labcorp’s management says.
More evidence of sponsor demand for direct-to-patient (DTP) services with Marken announcing an expansion of its deal with GlobalCare Clinical Trials just a week after rival Almac launched its to-the-door study drug delivery offering in Europe.
UDG Healthcare is selling its United Drug Supply Chain Services to distribution giant McKesson for €407.5m ($466.5m).
Polish preclinical services company Selvita has opened offices in Boston and San Francisco in the US citing proximity to customers as the driver.
Interchangeability can create long-lasting price competition in the nascent US biosimilars market according to a Berkeley health policy expert.